Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market
Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.
Doverie is one of the largest private health insurance companies in Bulgaria. As one of the first health insurance funds in the country, it ranked among the top three in 2024 by premium revenue.
Generali, the Italian insurance company and one of the world’s leading insurance providers, has acquired Doverie as part of its growth strategy in the Central and Eastern Europe (CEE) region. With this acquisition, Generali will become the second-largest player in Bulgaria’s health insurance market.
Doverie United Holding is a renowned publicly listed equity fund in Bulgaria, with a diverse portfolio that includes 18 companies across eight economic sectors.
Oaklins’ team in Bulgaria acted as the exclusive sell-side M&A adviser to Doverie United Holding, assisting the client throughout the entire divestment process.
We are now delighted that, with this transaction, Doverie has found in Generali the strategic partner that can continue the development trajectory of the business and bring it to the next level of growth. We are also thankful to Oaklins Bulgaria for its professionalism and dedication throughout the deal. The team at Oaklins Bulgaria was instrumental in managing the relationship between all of the stakeholders, the negotiation process and the execution of the transaction.»
Alexander Hristov
CEO, Doverie United Holding
Contacter l'équipe de la transaction
Transactions connexes
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
En apprendre plusAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
En apprendre plusXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
En apprendre plus